Pharma Taken With EU Pilot On Merging Licenses From Mutual Recognition/Decentralized Procedures
This article was originally published in The Pink Sheet Daily
Project emerging from generic industry proposal could aid companies in handing post-marketing procedures, and reduce regulatory complexity.
You may also be interested in...
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
A first-of-its-kind collaborative study has found that real-world and natural history data are comparable to placebo data from clinical trials in Duchenne muscular dystrophy.
An EU group has listed several ambitious projects to help EU regulators realize their cherished vision of using big data capabilities to support innovation and public health. But these proposals may take a backseat as COVID-19-related challenges continue.